πŸ‡ΊπŸ‡Έ FDA
Patent

US 6930185

Melanin-concentrating hormone antagonist

expired A61PA61P3/04A61P43/00

Quick answer

US patent 6930185 (Melanin-concentrating hormone antagonist) held by Takeda Chemical Industries Ltd. expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P3/04, A61P43/00